Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2012 Aug 30;68(Pt 9):1055–1059. doi: 10.1107/S1744309112032526

Crystallization and preliminary X-ray crystallographic analysis of subunit F (F1–94), an essential coupling subunit of the eukaryotic V1VO-ATPase from Saccharomyces cerevisiae

Sandip Basak a, Asha Manikkoth Balakrishna a, Malathy Sony Subramanian Manimekalai a, Gerhard Grüber a,*
PMCID: PMC3433196  PMID: 22949193

The S. cerevisiae V-ATPase subunit F (F1–94) protein and the selenomethionyl form of its I69M mutant protein were produced, purified and crystallized. X-ray diffraction data were collected to resolutions of 2.64 and 2.3 Å, respectively, and the crystals belonged to the orthorhombic space group C2221.

Keywords: subunit F, V1VO-ATPases, Saccharomyces cerevisiae, selenomethionine

Abstract

V-ATPases are very complex multi-subunit enzymes which function as proton-pumping rotary nanomotors. The rotary and coupling subunit F (F1–94) was crystallized by the hanging-drop vapour-diffusion method. The native crystals diffracted to a resolution of 2.64 Å and belonged to space group C2221, with unit-cell parameters a = 47.21, b = 160.26, c = 102.49 Å. The selenomethionyl form of the F1–94 I69M mutant diffracted to a resolution of 2.3 Å and belonged to space group C2221, with unit-cell parameters a = 47.22, b = 160.83, c = 102.74 Å. Initial phasing and model building suggested the presence of four molecules in the asymmetric unit.

1. Introduction  

Eukaryotic V-ATPases are ubiquitous proton pumps which use the energy of ATP hydrolysis to translocate protons from the cytosol to intracellular compartments or extracellular space. V-ATPase is one of the key proteins that maintain pH homeostasis at both the cellular and the whole organism level (Saroussi & Nelson, 2009 ▶; Beyenbach & Wieczorek, 2006 ▶). The enzyme has been described to be an important component of the endosomal sensing machinery (Marshansky, 2007 ▶). Eukaryotic V1VO-ATPases consist of a water-soluble V1 subcomplex and an integral membrane VO subcomplex (Fig. 1 ▶; Lolkema et al., 2003 ▶; Grüber & Marshansky, 2008 ▶). Hydrolysis of ATP is carried out in the V1 headpiece consisting of an A3:B3 hexamer, and the energy released is transmitted to the membrane-bound VO domain to drive proton translocation. The coupling of energy occurs via the stalk structure, which is an assembly of V1 subunits C–H and VO subunits a and d that forms the structural and functional interface. The proposed subunit stoichiometries of the V1 and VO domains are A3:B3:C1:D1:E1:F1:G2:Hx (Grüber & Marshansky, 2008 ▶) and a 1:d 1:c 4–5:c 1′:c 1′′ (Nishi & Forgac, 2002 ▶), respectively. To date, the structures of subunits C (Drory et al., 2004 ▶), G (Rishikesan et al., 2009 ▶, 2010 ▶) and H (Sagermann et al., 2001 ▶) of the stalk region of the Saccharomyces cerevisiae V1VO-ATPase have been determined to high resolution. Subunit C is formed by an upper head domain, a large globular foot and an elongated neck domain (Drory et al., 2004 ▶). The elongated subunit G is mainly α-helical (Rishikesan et al., 2009 ▶, 2010 ▶), whereas stalk subunit H is characterized by a large primarily α-helical N-­terminal domain that forms a shallow groove and a C-terminal domain connected by a four-residue loop (Sagermann et al., 2001 ▶).

Figure 1.

Figure 1

Schematic diagram of the V1 (blue) and VO sections (orange) of the eukaryotic vacuolar ATPases. In eukaryotic V1VO-ATPases the V1 part can be reversibly disassembled from the VO section as indicated by the arrow.

Subunit F, together with subunit D, which is a part of the central stalk, is directly involved in the hydrolytic cleavage of ATP in the A3B3 headpiece of the V1 sector, with the proton pumping in the VO part (Radermacher et al., 2001 ▶). It has been proposed that subunit F makes structural alterations during catalysis by way of interacting with subunits A, D and E in a nucleotide-dependent manner (Grüber et al., 2000 ▶; Coskun et al., 2004 ▶). Furthermore, in the free V1-ATPase it has also been shown that subunit F interacts with subunit H in an inhibitory mode by reducing ATP hydrolysis (Parra et al., 2000 ▶; Jefferies & Forgac, 2007 ▶). Recently, we determined the solution shape of the S. cerevisiae V-ATPase subunit F (118 amino acids) using small-angle X-ray scattering, revealing subunit F to be a long egg-shaped protein which is connected via a linker to a hook-like segment (Basak et al., 2011 ▶). By producing and determining the solution shape of a C-­terminally truncated form of subunit F (F1–94), the hook-like region could be identified as being formed by the very C-terminus of subunit F (Basak et al., 2011 ▶). The NMR solution structure of this C-terminal peptide F90–116 has been solved, displaying a loop region connected to an α-helical segment (Basak et al., 2011 ▶). In order to understand the function of the essential coupling and rotation of subunit F, a high-resolution structure of F1–94 is needed. Here, we have produced, purified and crystallized F1–94; the crystals diffracted to 2.64 Å resolution. Since subunit F1–94 has only one methionine as the first amino acid, a selenomethionyl form of the F1–94 I69M mutant was produced and crystallized. These crystals diffracted to a resolution of 2.3 Å.

2. Materials and methods  

2.1. Cloning and overexpression  

The native F1–94 protein was produced as recently described (Basak et al., 2011 ▶; Swiss-Prot accession No. P39111). The I69M mutant of S. cerevisiae F1–94 (with a calculated molecular mass of 10 656.03 Da and an isoelectric point of 4.59) was produced by the overlap extension polymerase chain reaction (PCR) method using a subunit F1–94 insert in pET9d1 vector (Basak et al., 2011 ▶) as a template. In two PCR reactions, flanking primers 5′-GTAACTAAACCATGGCTGAGAAACGTACTCTTATAGCTGTG-3′ (forward primer a) and 5′-ATCGAGCTCTTAAATTTCTAAAATAGCAGGGAACGC-3′ (reverse primer d) incorporating NcoI and SacI (bold) restriction sites, respectively, were used that hybridized at each end of the F1–94 sequence. In addition, the internal primers 5′-GATATTGCCATCCTTCTAATGAACCAACATATCGC-3′ (forward primer b) and 5′-GCGATATGTTGGTTCATTAGAAGGATGGCAATATC-3′ (reverse primer c) were used to hybridize at the site of the mutation and contain mismatched bases (bold). In separate PCRs, two fragments of the subunit F1–94 gene were amplified using primer pairs a/b and c/d. The overlap allowed one strand from each fragment to act as a primer on the other, and extension of this overlap using the flanking primers (a and d) resulted in the mutant product. Following digestion with NcoI and SacI, the PCR product was ligated into the pET9d-His3 vector (Grüber et al., 2002 ▶). The resulting coding sequence included an N-terminal MKHHHHHHP tag. The mutation was verified by DNA sequencing. The verified plasmids were finally transformed into Escherichia coli BL21 (DE3) cells (Stratagene), which were grown on 30 µg ml−1 kanamycin-containing Luria–Bertani (LB) agar plates. The selenomethionine protein was produced in E. coli strain BL21 (DE3) cells by growing a 5 ml culture overnight at 310 K in LB medium containing kanamycin. The cells were pelleted by centrifugation and were washed twice with M9 minimal medium. The cell suspension was used to inoculate 1 l pre-warmed (310 K) M9 minimal medium and the cells were grown at 310 K. When the OD600 reached 0.6, the minimal medium was supplemented with 100 mg l−1 lysine, phenyl­alanine and threonine, 50 mg l−1 isoleucine, leucine and valine, and 50 mg l−1 selenomethionine. This medium was then shaken for a further 15 min. Thereafter, protein expression was induced by the addition of isopropyl β-d-1-thiogalactopyranoside to a final concentration of 1 mM and growth was continued at 293 K overnight.

2.2. Protein purification  

The native F1–94 protein of S. cerevisiae V-ATPase (VMA7p) was purified as recently described (Basak et al., 2011 ▶). The SeMet F1–94 I69M mutant was purified using a similar method to the native protein, except that dithiothreitol (DTT) was used in all buffers to avoid the oxidation of selenium. The cells were pelleted by centrifugation at 8500g for 12 min at 279 K. Subsequently, they were lysed on ice by sonication for 3 × 1 min in buffer A {50 mM HEPES pH 7.0, 300 mM NaCl, 0.8 mM DTT, 2 mM PMSF, 2 mM Pefabloc SC [4-­(2-­aminoethyl)benzenesulfonyl fluoride hydrochloride; Biomol]}. Precipitated material was separated by centrifugation at 10 000g for 35 min. The supernatant was filtered (0.45 µm; Millipore) and passed over a 3 ml Ni2+–NTA resin column to isolate subunit F1–94. The His-tagged protein was allowed to bind to the matrix for 1.5 h at 277 K and was eluted with an imidazole gradient (25–400 mM) in buffer A. Fractions containing F1–94 were identified by SDS–PAGE (Laemmli, 1970 ▶), pooled and concentrated as required using Centricon YM-3 (3 kDa molecular-mass cutoff) spin concentrators (Millipore). Imidazole was removed by gel-filtration chromatography using a Superdex 75 HR 10/30 column (GE Healthcare) and a buffer consisting of 50 mM HEPES pH 7.0, 300 mM NaCl, 1 mM DTT, 5 mM EDTA. The purity and homogeneity of the protein samples were analyzed by SDS–PAGE (Laemmli, 1970 ▶) and the gels were stained with Coomassie Brilliant Blue G250. Protein concentrations were determined using the bicinchoninic acid assay (BCA; Pierce, Rockford, Illinois, USA).

2.3. Crystallization conditions  

The purified native F1–94 was concentrated to 3 mg ml−1 in buffer consisting of 50 mM HEPES pH 7.0, 300 mM NaCl, 5 mM EDTA using a 3 kDa cutoff concentrator. Initial crystallization screening was carried out by the hanging-drop vapour-diffusion method at 291 K using Crystal Screen and Crystal Screen 2 from Hampton Research, USA (Jancarik & Kim, 1991 ▶) and Wizard I and II from Emerald BioSystems, USA in 48-well VDX plates (Hampton Research, USA). Small crystals appeared after 3–4 d in Crystal Screen condition No. 6 [30%(w/v) polyethylene glycol (PEG) 4000, 0.2 M MgCl2, 0.1 M Tris–­HCl pH 8.5]. The crystals were optimized by systematically performing grid screens by varying the concentrations of the precipitant and salt, the buffer pH and the protein concentration. Further optimization was performed by using various additives. The best crystals appeared in 30% PEG 4000, 0.1 M MgCl2, 0.1 M Tris–HCl pH 8.8, 10% glycerol. The SeMet F1–94 I69M mutant protein gave small crystals under the same conditions as used for the native F1–94 and was therefore further optimized. A good crystal of diffraction quality appeared within a day in 30% PEG 4000, 0.05 M MgCl2, 0.1 M Tris–HCl pH 8.8, 10% glycerol with a 5 mg ml−1 protein concentration at 291 K.

2.4. X-ray data collection and analysis  

The native crystals were quick-soaked in a cryoprotectant solution containing 25% glycerol in mother liquor and flash-cooled in liquid nitrogen. The SeMet F1–94 I69M mutant crystals were transferred to stabilizing solution (32% PEG 4000, 0.05 M MgCl2, 0.1 M Tris–HCl pH 8.8, 10% glycerol) and the crystals were cryoprotected in the same stabilizing solution containing 22% glycerol and flash-cooled in liquid nitrogen. A single-wavelength data set was collected from a native F1–­94 crystal in-house at 100 K on a Rigaku R-AXIS IV image-plate detector with a Rigaku RA-Micro 7 HFM rotating copper-anode generator (Rigaku/MSC). 360 frames were collected with an oscillation range of 1° and an exposure time of 5 min per frame. For the SeMet F1–94 I69M mutant protein crystal, a three-wavelength multiwavelength anomalous diffraction (MAD) data set was collected at 100 K on beamline 13B1 at the National Synchrotron Radiation Research Center (NSRRC), Hsinchu, Taiwan using an ADSC Quantum 315 CCD detector. A single crystal was used to collect data at appropriate inflection, peak and high remote wavelengths based on the selenium absorption spectrum. Data were collected as a series of 0.5° oscillation images with 5 s exposure time, covering crystal rotation ranges of 360° for the peak wavelength and 180° for the inflection and high remote wavelengths. The inflection and high remote wavelength data sets were initially collected, followed by the peak wavelength data set. All diffraction data were indexed, integrated and scaled using the HKL-2000 suite of programs (Otwinowski & Minor, 1997 ▶). The results of data processing and the data statistics are summarized in Table 1 ▶.

Table 1. Statistics of data collection and processing for F1–94 and the SeMet F1–94 I69M mutant protein.

Values in parentheses are for the highest resolution shell.

    SeMet F1–94 I69M mutant
  F1–94 Peak Inflection Remote
Wavelength (Å) 1.54178 0.978683 0.978836 0.963626
Space group C2221 C2221 C2221 C2221
Unit-cell parameters (Å)
  a 47.206 47.223 47.146 47.153
  b 160.264 160.833 160.312 160.334
  c 102.494 102.738 102.429 102.439
Molecules in asymmetric unit 4 4 4 4
Solvent content (%) 46.03 46.28 45.86 45.87
Resolution limits (Å) 30.0–2.64 (2.73–2.64) 50.0–2.45 (2.54–2.45) 50.0–2.33 (2.41–2.33) 50.0–2.29 (2.37–2.29)
No. of images 360 720 360 360
No. of reflections 26881 33722 38421 40195
Unique reflections 11788 14946 17096 17958
Multiplicity 6.4 (6.3) 12.7 (6.4) 6.5 (4.6) 6.4 (3.7)
Completeness (%) 98.9 (99.0) 99.4 (95.9) 99.5 (96.7) 98.8 (89.5)
R merge † (%) 10.2 (28.0) 9.4 (58.6) 8.4 (43.4) 8.4 (45.9)
〈I/σ(I)〉 13.7 (7.1) 23.4 (1.8) 18.8 (2.2) 17.1 (1.6)
†

R merge = Inline graphic Inline graphic, where 〈I(hkl)〉 is the mean intensity for reflection hkl.

3. Results and discussion  

3.1. Protein characterization  

The S. cerevisiae V-ATPase subunit F (F1–94) and the SeMet F1–94 I69M mutant protein were purified initially by Ni2+–NTA affinity chromatography using an imidazole gradient and subsequently by size-exclusion chromatography to isolate a pure protein of about 11 kDa (Fig. 2 ▶). Good diffraction-quality crystals were obtained by modifying the initial condition by varying the precipitant, salt and protein concentrations and the buffer pH. Typical crystals of F1–94 and the SeMet F1–94 I69M mutant are shown in Fig. 3 ▶.

Figure 2.

Figure 2

Chromatogram of the gel-filtration analysis at 280 nm absorbance for the SeMet F1–­94 I69M mutant. Insert, SDS gel (17% total acrylamide and 0.4% cross-linked acrylamide) of the purified SeMet F1–­94 I69M mutant protein of the V-ATPase from S. cerevisiae after purification on Ni2+–NTA resin (lane 1) and the indicated fraction from the elution peak after Superdex 75 purification (lane 2).

Figure 3.

Figure 3

Crystal photographs of (a) native F1–94 (0.4 × 0.07 × 0.03 mm) and (b) SeMet F1–94 I69M mutant protein (0.45 × 0.08 × 0.04 mm) from the S. cerevisiae V-ATPase.

3.2. Crystallization and preliminary X-ray analysis  

The native F1–94 crystallized in the orthorhombic space group C2221, with unit-cell parameters a = 47.21, b = 160.26, c = 102.49 Å, and the crystals diffracted to a maximum resolution of 2.64 Å. A representative diffraction pattern is presented in Fig. 4 ▶(a). Assuming the presence of four molecules in the asymmetric unit, the solvent content is 46.03% and the Matthews coefficient (V M) is 2.28 Å3 Da−1 (Matthews, 1968 ▶). Initial attempts at phasing by molecular replacement using the structures of subunit F of the related A-ATP synthases from Pyrococcus furiosus (PDB entry 2qai; Northeast Structural Genomics Consortium, unpublished work) and Archaeoglobus fulgidus (PDB entry 2i4r; Northeast Structural Genomics Consortium, unpublished work) were unsuccessful. A fluorescence scan of the selenomethionine-substituted native F1–94 crystals yielded a weak signal at the selenium absorption edge with no useful anomalous signal for phase determination. This is most probably owing to the fact that the only available methionine in this protein is at the very N-­terminus of the amino-acid sequence. Therefore, the F1–94 I69M mutant was generated and the selenomethionyl form was produced. The SeMet F1–94 I69M mutant crystals diffracted to a resolution of 2.3 Å (Fig. 4 ▶ b) and belonged to space group C2221, with unit-cell parameters a = 47.22, b = 160.83, c = 102.74 Å. Based on the solvent content of 46.28% and the V M of 2.29 Å3 Da−1, four molecules per asymmetric unit were assumed. Phasing is being carried out by a three-wavelength MAD technique.

Figure 4.

Figure 4

Representative diffraction images of (a) native F1–94 and (b) the SeMet F1–94 I69M mutant from the S. cerevisiae V-ATPase. Resolution circles corresponding to 4.5 and 3.0 Å are shown.

Acknowledgments

We thank the staff of beamline 13B1 at the National Synchrotron Radiation Research Centre (NSRRC), a national user facility supported by the National Science Council of Taiwan, ROC, for expert help with data collection. The Synchrotron Radiation Protein Crystallography Facility at NSRRC is supported by the National Research Program for Genomic Medicine. SB is grateful to Nanyang Technological University for the award of a research scholarship. This study was supported by A*STAR BMRC (09/1/22/19/609) to GG.

References

  1. Basak, S., Gayen, S., Thaker, Y. R., Manimekalai, M. S. S., Roessle, M., Hunke, C. & Grüber, G. (2011). Biochim. Biophys. Acta, 1808, 360–368. [DOI] [PubMed]
  2. Beyenbach, K. W. & Wieczorek, H. (2006). J. Exp. Biol. 209, 577–589. [DOI] [PubMed]
  3. Coskun, U., Rizzo, V. F., Koch, M. H. J. & Grüber, G. (2004). J. Bioenerg. Biomembr. 36, 249–256. [DOI] [PubMed]
  4. Drory, O., Frolow, F. & Nelson, N. (2004). EMBO Rep. 5, 1148–1152. [DOI] [PMC free article] [PubMed]
  5. Grüber, G., Godovac-Zimmermann, J., Link, T. A., Coskun, U., Rizzo, V. F., Betz, C. & Bailer, S. M. (2002). Biochem. Biophys. Res. Commun. 298, 383–391. [DOI] [PubMed]
  6. Grüber, G. & Marshansky, V. (2008). Bioessays, 30, 1096–1109. [DOI] [PubMed]
  7. Grüber, G., Radermacher, M., Ruiz, T., Godovac-Zimmermann, J., Canas, B., Kleine-Kohlbrecher, D., Huss, M., Harvey, W. R. & Wieczorek, H. (2000). Biochemistry, 39, 8609–8616. [DOI] [PubMed]
  8. Jancarik, J. & Kim, S.-H. (1991). J. Appl. Cryst. 24, 409–411.
  9. Jefferies, K. C. & Forgac, M. (2007). J. Biol. Chem. 283, 4512–4519. [DOI] [PMC free article] [PubMed]
  10. Laemmli, U. K. (1970). Nature (London), 227, 680–685. [DOI] [PubMed]
  11. Lolkema, J. S., Chaban, Y. & Boekema, E. J. (2003). J. Bioenerg. Biomembr. 35, 323–335. [DOI] [PubMed]
  12. Marshansky, V. (2007). Biochem. Soc. Trans. 35, 1092–1099. [DOI] [PubMed]
  13. Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
  14. Nishi, T. & Forgac, M. (2002). Nature Mol. Cell Biol. 30, 94–103. [DOI] [PubMed]
  15. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. [DOI] [PubMed]
  16. Parra, K. J., Keenan, K. L. & Kane, P. M. (2000). J. Biol. Chem. 275, 21761–21767. [DOI] [PubMed]
  17. Radermacher, M., Ruiz, T., Wieczorek, H. & Grüber, G. (2001). J. Struct. Biol. 135, 26–37. [DOI] [PubMed]
  18. Rishikesan, S., Gayen, S., Thaker, R. Y., Vivekanandan, S., Manimekalai, M. S. S., Yau, Y. H., Shochat, S. G. & Grüber, G. (2009). Biochim. Biophys. Acta, 1787, 242–251. [DOI] [PubMed]
  19. Rishikesan, S., Manimekalai, M. S. S. & Grüber, G. (2010). Biochim. Biophys. Acta, 1788, 1961–1968. [DOI] [PubMed]
  20. Sagermann, M., Stevens, T. H. & Matthews, B. W. (2001). Proc. Natl Acad. Sci. USA, 98, 7134–7139. [DOI] [PMC free article] [PubMed]
  21. Saroussi, S. & Nelson, N. (2009). Eur. J. Physiol. 457, 581–587. [DOI] [PubMed]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES